Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats

Frontiers in Neuroscience

Volumn 9, Issue NOV, 2015, Pages

  Momeni, Shima ^a   Segerström, Lova ^a   Roman, Erika ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alcohol use disorder; Behavior; Individual differences; Open field; Prefrontal cortex; Spontaneous alternations; Strain variation; Y maze

Indexed keywords

NALTREXONE;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR ASSESSMENT; BODY WEIGHT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRINKING BEHAVIOR; DRUG RESPONSE; FLUID INTAKE; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; RAT;

EID: 84949570666     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00424     Document Type: Article

References (59)

1. Adermark, L., Jonsson, S., Ericson, M., and Söderpalm, B. (2011). Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat. Neuropharmacology 61, 1160-1165. doi: 10.1016/j.neuropharm.2011.01.014.
2. Balogh, K. N., Mayes, L. C., and Potenza, M. N. (2013). Risk-taking and decision-making in youth: relationships to addiction vulnerability. J. Behav. Addict. 2, 1-9. doi: 10.1556/JBA.2.2013.1.1.
3. Barson, J. R., Fagan, S. E., Chang, G. Q., and Leibowitz, S. F. (2013). Neurochemical heterogeneity of rats predicted by different measures to be high ethanol consumers. Alcohol. Clin. Exp. Res. 37, E141-E151. doi: 10.1111/J.1530-0277.2012.01858.X.
4. Bazov, I., Kononenko, O., Watanabe, H., Kuntic, V., Sarkisyan, D., Taqi, M. M., et al. (2013). The endogenous opioid system in human alcoholics: molecular adaptations in brain areas involved in cognitive control of addiction. Addict. Biol. 18, 161-169. doi: 10.1111/j.1369-1600.2011.00366.x.
5. Becker, H. C. (2013). Animal models of excessive alcohol consumption in rodents. Curr. Top. Behav. Neurosci. 13, 355-377. doi: 10.1007/7854_2012_203.
6. Carnicella, S., Ron, D., and Barak, S. (2014). Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol 48, 243-252. doi: 10.1016/j.alcohol.2014.01.006.
7. Cichelli, M. J., and Lewis, M. J. (2002). Naloxone nonselective suppression of drinking of ethanol, sucrose, saccharin, and water by rats. Pharmacol. Biochem. Behav. 72, 699-706. doi: 10.1016/S0091-3057(02)00736-0.
8. Clause, B. T. (1993). The Wistar rat as a right choice-establishing mammalian standards and the ideal of a standardized mammal. J. Hist. Biol. 26, 329-349. doi: 10.1007/Bf01061973.
9. Crabbe, J. C. (2014). Use of animal models of alcohol-related behavior. Handb. Clin. Neurol. 125, 71-86. doi: 10.1016/B978-0-444-62619-6.00005-7.
10. Crabbe, J. C., Bell, R. L., and Ehlers, C. L. (2010). Human and laboratory rodent low response to alcohol: is better consilience possible? Addict. Biol. 15, 125-144. doi: 10.1111/j.1369-1600.2009.00191.x.
11. Daoura, L., and Nylander, I. (2011). The response to naltrexone in ethanol-drinking rats depends on early environmental experiences. Pharmacol. Biochem. Behav. 99, 626-633. doi: 10.1016/j.pbb.2011.06.004.
12. Escher, T., and Mittleman, G. (2006). Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone. Addict. Biol. 11, 55-63. doi: 10.1111/j.1369-1600.2006.00004.x.
13. Everitt, B. J., and Robbins, T. W. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 1481-1489. doi: 10.1038/nn1579.
14. Everitt, J. I. (2015). The future of preclinical animal models in pharmaceutical discovery and development: a need to bring in cerebro to the in vivo discussions. Toxicol. Pathol. 43, 70-77. doi: 10.1177/0192623314555162.
15. Fredriksson, I., Jayaram-Lindström, N., Wirf, M., Nylander, E., Nyström, E., Jardemark, K., et al. (2015). Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings. Neuropsychopharmacology 40, 1130-1140. doi: 10.1038/Npp.2014.294.
16. Garbutt, J. C., Greenblatt, A. M., West, S. L., Morgan, L. C., Kampov-Polevoy, A., Jordan, H. S., et al. (2014). Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence. Addiction 109, 1274-1284. doi: 10.1111/add.12557.
17. George, O., and Koob, G. F. (2010). Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 35, 232-247. doi: 10.1016/J. Neubiorev.2010.05.002.
18. Goepfrich, A. A., Gluch, C., Friemel, C. M., and Schneider, M. (2013). Behavioral differences in three Wistar Han rat lines for emotional reactivity, cognitive processing and ethanol intake. Physiol. Behav. 110-111, 102-108. doi: 10.1016/j.physbeh.2012.12.019.
19. Goldstein, R. Z., and Volkow, N. D. (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 12, 652-669. doi: 10.1038/Nrn3119.
20. Gotesson, J., Ericson, M., Soderpalm, B., and Pickering, C. (2012). Repeated ethanol but not phencyclidine impairs spontaneous alternation behaviour in the Y-maze. Basic Clin. Pharmacol. Toxicol. 110, 347-352. doi: 10.1111/j.1742-7843.2011.00819.x.
21. Gowin, J. L., Mackey, S., and Paulus, M. P. (2013). Altered risk-related processing in substance users: imbalance of pain and gain. Drug Alcohol Depend. 132, 13-21. doi: 10.1016/j.drugalcdep.2013.03.019.
22. Hines, L. M., Ray, L., Hutchison, K., and Tabakoff, B. (2005). Alcoholism: the dissection for endophenotypes. Dialogues Clin. Neurosci. 7, 153-163.
23. Howells, D. W., Sena, E. S., and Macleod, M. R. (2014). Bringing rigour to translational medicine. Nat. Rev. Neurol. 10, 37-43. doi: 10.1038/nrneurol.2013.232.
24. Karlsson, O., Roman, E., and Brittebo, E. B. (2009). Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine. Toxicol. Sci. 112, 185-195. doi: 10.1093/toxsci/kfp196.
25. Koob, G. F. (2014). Neurocircuitry of alcohol addiction: synthesis from animal models. Handb. Clin. Neurol. 125, 33-54. doi: 10.1016/b978-0-444-62619-6.00003-3.
26. Kranzler, H. R., Armeli, S., Tennen, H., Blomqvist, O., Oncken, C., Petry, N., et al. (2003). Targeted naltrexone for early problem drinkers. J. Clin. Psychopharmacol. 23, 294-304. doi: 10.1097/01.jcp.0000084030.22282.6d.
27. Krishnan-Sarin, S., Krystal, J. H., Shi, J., Pittman, B., and O'Malley, S. S. (2007). Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol. Psychiatry 62, 694-697. doi: 10.1016/j.biopsych.2006.11.018.
28. Lalonde, R. (2002). The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 26, 91-104. doi: 10.1016/S0149-7634(01)00041-0.
29. Lang, I. M., Strahlendorf, J. C., Strahlendorf, H. K., Lutherer, L. O., and Barnes, C. D. (1982). The effects of chronic administration of naltrexone on appetite and water exchange in rats. Pharmacol. Biochem. Behav. 16, 909-913.
30. Leggio, L., Kenna, G. A., Fenton, M., Bonenfant, E., and Swift, R. M. (2009). Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol. Rev. 19, 115-129. doi: 10.1007/s11065-008-9080-z.
31. Meyerson, B. J., Augustsson, H., Berg, M., and Roman, E. (2006). The Concentric Square Field: a multivariate test arena for analysis of explorative strategies. Behav. Brain Res. 168, 100-113. doi: 10.1016/j.bbr.2005.10.020.
32. Mitchell, J. M., Bergren, L. J., Chen, K. S., Rowbotham, M. C., and Fields, H. L. (2009). Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiol. Dis. 33, 72-80. doi: 10.1016/J. Nbd.2008.09.018.
33. Momeni, S., and Roman, E. (2014). Subgroup-dependent effects of voluntary alcohol intake on behavioral profiles in outbred Wistar rats. Behav. Brain Res. 275, 288-296. doi: 10.1016/j.bbr.2014.08.058.
34. Momeni, S., Sharif, M., Agren, G., and Roman, E. (2014). Individual differences in risk-related behaviors and voluntary alcohol intake in outbred Wistar rats. Behav. Pharmacol. 25, 206-215. doi: 10.1097/FBP.0000000000000036.
35. Nutt, D. J., and Rehm, J. (2014). Doing it by numbers: a simple approach to reducing the harms of alcohol. J. Psychopharmacol. 28, 3-7. doi: 10.1177/0269881113512038.
36. Nylander, I., and Roman, E. (2013). Is the rodent maternal separation model a valid and effective model for studies on the early-life impact on ethanol consumption? Psychopharmacology 229, 555-569. doi: 10.1007/S00213-013-3217-3.
37. Oliva, J. M., and Manzanares, J. (2007). Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats. Neuropsychopharmacology 32, 1358-1369. doi: 10.1038/sj.npp.1301237.
38. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E., and Rounsaville, B. (1992). Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry 49, 881-887.
39. Oswald, L. M., and Wand, G. S. (2004). Opioids and alcoholism. Physiol. Behav. 81, 339-358. doi: 10.1016/j.physbeh.2004.02.008.
40. Palm, S., Havermark, A., Meyerson, B. J., Nylander, I., and Roman, E. (2011a). When is a Wistar a Wistar? Behavioral profiling of outbred Wistar rats from five different suppliers using the MCSF test. Appl. Anim. Behav. Sci. 135, 128-137. doi: 10.1016/J. Applanim.2011.08.010.
41. Palm, S., Roman, E., and Nylander, I. (2011b). Differences in voluntary ethanol consumption in Wistar rats from five different suppliers. Alcohol 45, 607-614. doi: 10.1016/j.alcohol.2010.11.005.
42. Palm, S., Roman, E., and Nylander, I. (2012). Differences in basal and ethanol-induced levels of opioid peptides in Wistar rats from five different suppliers. Peptides 36, 1-8. doi: 10.1016/j.peptides.2012.04.016.
43. Palmer, R. H., Young, S. E., Corley, R. P., Hopfer, C. J., Stallings, M. C., and Hewitt, J. K. (2013). Stability and change of genetic and environmental effects on the common liability to alcohol, tobacco, and cannabis DSM-IV dependence symptoms. Behav. Genet. 43, 374-385. doi: 10.1007/s10519-013-9599-5.
44. Pickering, C., Alsiö, J., Morud, J., Ericson, M., Robbins, T. W., and Söderpalm, B. (2015). Ethanol impairment of spontaneous alternation behaviour and associated changes in medial prefrontal glutamatergic gene expression precede putative markers of dependence. Pharmacol. Biochem. Behav. 132, 63-70. doi: 10.1016/j.pbb.2015.02.021.
45. Reid, L. D. (1985). Endogenous opioid peptides and regulation of drinking and feeding. Am. J. Clin. Nutr. 42, 1099-1132.
46. Roman, E., Stewart, R. B., Bertholomey, M. L., Jensen, M. L., Colombo, G., Hyytiä, P., et al. (2012). Behavioral profiling of multiple pairs of rats selectively bred for high and low alcohol intake using the MCSF test. Addict. Biol. 17, 33-46. doi: 10.1111/J.1369-1600.2011.00327.X.
47. Simms, J. A., Steensland, P., Medina, B., Abernathy, K. E., Chandler, L. J., Wise, R., et al. (2008). Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol. Clin. Exp. Res. 32, 1816-1823. doi: 10.1111/j.1530-0277.2008.00753.x.
48. Söderpalm, B., and Ericson, M. (2013). Neurocircuitry involved in the development of alcohol addiction: the dopamine system and its access points. Curr. Top. Behav. Neurosci. 13, 127-161. doi: 10.1007/7854_2011_170.
49. Steensland, P., Fredriksson, I., Holst, S., Feltmann, K., Franck, J., Schilström, B., et al. (2012). The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. Biol. Psychiatry 72, 823-831. doi: 10.1016/j.biopsych.2012.06.018.
50. Stewart, A. M., and Kalueff, A. V. (2015). Developing better and more valid animal models of brain disorders. Behav. Brain Res. 276, 28-31. doi: 10.1016/j.bbr.2013.12.024.
51. Suchankova, P., Steensland, P., Fredriksson, I., Engel, J. A., and Jerlhag, E. (2013). Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS ONE 8:e71284. doi: 10.1371/journal.pone.0071284.
52. Tabakoff, B., and Hoffman, P. L. (2013). The neurobiology of alcohol consumption and alcoholism: an integrative history. Pharmacol. Biochem. Behav. 113, 20-37. doi: 10.1016/j.pbb.2013.10.009.
53. Thorsell, A. (2013). The mu-opioid receptor and treatment response to naltrexone. Alcohol Alcohol. 48, 402-408. doi: 10.1093/alcalc/agt030.
54. Trigo, J. M., Martin-García, E., Berrendero, F., Robledo, P., and Maldonado, R. (2010). The endogenous opioid system: a common substrate in drug addiction. Drug Alcohol Depend. 108, 183-194. doi: 10.1016/j.drugalcdep.2009.10.011.
55. Volpicelli, J. R., Alterman, A. I., Hayashida, M., and O'Brien, C. P. (1992). Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49, 876-880.
56. Volpicelli, J. R., Volpicelli, L. A., and O'Brien, C. P. (1995). Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment. Alcohol Alcohol. 30, 789-798.
57. Wayner, M. J., Greenberg, I., Tartaglione, R., Nolley, D., Fraley, S., and Cott, A. (1972). A new factor affecting the consumption of ethyl alcohol and other sapid fluids. Physiol. Behav. 8, 345-362.
58. Williams, K. L., and Broadbridge, C. L. (2009). Potency of naltrexone to reduce ethanol self-administration in rats is greater for subcutaneous versus intraperitoneal injection. Alcohol 43, 119-126. doi: 10.1016/j.alcohol.2008.11.003.
59. Wise, R. A. (1973). Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 29, 203-210.